Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ForSight VISION5, Inc.

Home Clinical Trial Sponsors and OrganizationsForSight VISION5, Inc.

ForSight VISION5, Inc.

ACTIVE

加利福尼亚州圣马特奥县, California, United Statesforsightvision5.comSubsidiary11–50 employeesEstablished: 2010-01-01

Part of Allergan Ltd. (Ireland)

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

8

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

2010

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 2

4

50.0%

Phase 1

3

37.5%

Trial Status Distribution

Completed

8

100.0%

Clinical Trials

Trials sponsored by this organization (8)

A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension

Apr 201655 participants

An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert

Aug 201581 participants

Bimatoprost Ocular Insert Pharmacokinetic Study

Mar 201511 participants

Dose-Ranging Study of the Bimatoprost Ocular Insert

Jan 2015156 participants

Survey of Patients Taking IOP-Lowering Eye Drops

Jan 2015160 participants

An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product

Jun 201475 participants

Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension

Oct 2013169 participants

A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension

Oct 201314 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials8
Approvals
News

Back to Organizations